Susan Jean Wallcraft
Directeur/Membre du Conseil chez Amnesty International Charity Ltd.
Profil
Susan Jean Wallcraft is currently the Director at Amnesty International Charity Ltd.
since 2017.
Previously, she worked as the Director at Pfizer Consumer Healthcare (United Kingdom) from 2009 to 2011 and as the Secretary at Ligand UK Ltd.
from 2018 to 2019.
Postes actifs de Susan Jean Wallcraft
| Sociétés | Poste | Début |
|---|---|---|
Amnesty International Charity Ltd.
 Amnesty International Charity Ltd. Miscellaneous Commercial ServicesCommercial Services Amnesty International Charity Ltd. was founded in 1986 and promotes and protects human rights. The non-profit company is based in London, UK. | Directeur/Membre du Conseil | 28/05/2017 |
Anciens postes connus de Susan Jean Wallcraft
| Sociétés | Poste | Fin |
|---|---|---|
| VERNALIS | Secrétaire Général | 31/03/2019 |
Pfizer Consumer Healthcare (United Kingdom)
 Pfizer Consumer Healthcare (United Kingdom) Drugstore ChainsRetail Trade Pfizer Consumer Healthcare Ltd. wholesales pharmaceutical goods. The company was established in 1913 and is headquartered in Berks, GB. | Directeur/Membre du Conseil | 06/04/2011 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Pfizer Consumer Healthcare (United Kingdom)
Pfizer Consumer Healthcare (United Kingdom) Drugstore ChainsRetail Trade Pfizer Consumer Healthcare Ltd. wholesales pharmaceutical goods. The company was established in 1913 and is headquartered in Berks, GB. | Retail Trade |
Amnesty International Charity Ltd.
Amnesty International Charity Ltd. Miscellaneous Commercial ServicesCommercial Services Amnesty International Charity Ltd. was founded in 1986 and promotes and protects human rights. The non-profit company is based in London, UK. | Commercial Services |
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |